Background: Peripheral arterial disease (PAD) is a marker of increased risk for cardiovascular events and of poorer prognosis in patients with coronary artery disease (CAD). The prevalence of unknown PAD amongst patients with ACS varies between studies according to the mode of diagnosis.
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Association between Peripheral Arterial Disease and Coronary Artery Disease among Tobacco User Diabetic Patients
Syed Dawood Md. Taimur presence of occlusive arterial disease, which cause inadequate blood flow to the limbs. On most occasions, the underlying disease process is arteriosclerotic in nature , mainly affecting the blood supply to the lower limbs. From the physiologic point of view, ischemia of the lower limbs can be classified as functional or critical. Functional ischemia occurs when the blood flow is normal at rest but insufficient during exercise, presenting clinically as intermittent claudication. Critical ischemia is produced when the reduction in blood flow results in a perfusion deficit at rest and is defined by the presence of pain at rest or trophic lesions in the legs. In this situation, precise diagnosis is fundamental, as there exist a clear risk of loss of the limb if adequate blood flow is not reestablished, either by surgery or by endovascular therapy.
PAD is a common disorder but because it is not directly life-threatening, it has not received the same degree of attention or research as coronary heart disease. But PAD may be a precursor of coronary heart disease since people with narrowed peripheral arteries are also more likely to have a narrowing of the coronary arteries. PAD mostly occurs in the elderly. In the United Kingdom around 1 in 5 men and 1 in 8 women aged 50-75 years have PAD 1 . PAD affects 8 to 10 million individuals in the United States 2.3 and is associated with reduced functional capacity [4] [5] [6] and increased risk for cardiovascular morbidity and mortality 7, 8 . About half of all people with PAD have no obvious symptoms and the first indication of peripheral arterial disease may be a coronary artery disease or cerebrovascular accident 1 . Approximately one third of patients diagnosed with PAD will die within five years and about one half die within ten years, primarily due to a coronary artery disease or cerebrovascular accident 1 .
Peripheral arterial disease (PAD) is one of the macrovascular complications of type 2 diabetes mellitus. Distribution of atheroma is widespread but patchy. Peripherally it effect femoro-popliteal segment, distal aorta and iliac arteries and lower leg arteries with a tendency to spare the profunda femoris beyond its origin of distal popliteal artery 9 . As global patterns in tobacco use changes, the burden of death can be expected to shift dramatically from the developed world to less wealthy countries. It has been estimated that over the next two decades, 70% of tobacco deaths will be in developing countries 10 . About 80% of the world's smokers now live in low and middle income countries, at least in part due to a lack of adequate tobacco controls 11 . In Bangladesh 43.3% of adults (41.3 million) currently use tobacco in smoking or smokeless form. Among them 26.4% of men, 28% of women and 27.2% overall (25.9 million adults) currently use smokeless tobacco 12 in different form like jorda, gul, hooka etc.
The most effective treatment for PAD is to stop tobacco use. This single measure reduces the risk of disease progression amongst patients with peripheral arterial disease and dramatically reduces the need for limb amputation and the risk of premature death.
Methodology:
Study population and design This prospective observational study was conducted in the Department of Cardiology, Ibrahim Cardiac Hospital & Research Institute, Dhaka for a period of 4 months starting from January, 2016 to April, 2016. A total of 60 ACS patients who were diabetic with and without tobacco user followed up during hospital period. Patients were categorized into two groups on the basis of tobacco use. Group I (diabetic ACS with tobacco user) had 30 patients and Group II (diabetic ACS without tobacco user) had 30 patients.
Diagnostic criteria
Cardiovascular risk factors
Subjects were defined as having hypertension if they were taking an anti-hypertensive agent, had been clinically diagnosed with hypertension (HTN), or had either a systolic blood pressure (SBP) ≥140 mm Hg or a diastolic blood pressure (DBP) ≥90 mm Hg. Subjects were defined to have dyslipidaemia if they met one of the following requirements: diagnosis of hypercholesterolemia or a medication history of hypercholesterolemia or Total Cholesterol >200 mg/dL or LDL-C >130 mg/dL. The following body mass index (BMI) categories were recognized: normal (18.5≤BMI<24.9), overweight (25≤BMI<30) and obese (BMI≥30). A patient who had smoked within a year prior to the study was defined as a smoker.
Ankle Brachial Index
The ankle-brachial pressure index (ABPI) or anklebrachial index (ABI) is the ratio of the blood pressure at the ankle to the blood pressure in the upper arm (brachium). Compared to the arm, lower blood pressure in the leg is an indication of blocked arteries due to peripheral artery disease (PAD). The ABPI is calculated by dividing the systolic blood pressure at the ankle by the systolic blood pressure in the arm 13 .
Where P Leg is the systolic blood pressure of dorsalis pedis or posterior tibial arteries And P Arm is the highest of the left and right arm brachial systolic blood pressure
The ABPI test is a popular tool for the non-invasive assessment of PVD. Studies have shown the sensitivity of ABPI is 90% with a corresponding 98% specificity for detecting hemodynamically significant (Serious) stenosis >50% in major leg arteries, defined by angiogram 14 . ABPI value of under 0.50,is considered as severe arterial disease 15 .
Statistical analysis
The age and gender differences and hypertension, diabetes, dyslipidaemia, smoking habit, family history of IHD,CKD, peripheral artery and coronary artery profile were statistically analyzed to find if they influenced in any way the incidence of standard deviation (SD). Data were entered in computer using SPSS for windows version 16.0 (SPSS Inc., Chicago, IL (Fig.-2) .
80% patients of group I and 46.7% patients of group II had mild form of ABI value. 3.3% of group II patients had severe form of ABI value. There was no statistical significant difference between the two group of patients (p=0.053) ( Table-III) . Over three quarters (76.7%) of group I patients developed PVD as compared to 33.3% of group II. The risk of developing PVD in diabetic smokers was observed to be more than 6 fold (95% CI: 2.109-20.479) higher than that in non diabetic tobacco user. (Table-4 ).
Twenty three patients of tobacco user group (n=30) had peripheral artery disease and ten patients of tobacco non user group (n=30) had peripheral artery disease which was statistically significant (p=0.003)( Table-5 ). Thirty three (55%) patients had peripheral artery disease in study population (n=60) and fifty seven patients had coronary artery disease. Out of thirty three patients who had diagnosed PVD, thirty two patients had coronary artery disease which was not statistically significant (p=0.424)( Table-6 ). 
Discussion:
The presence of peripheral arterial disease (PAD), even in the absence of overt coronary artery disease (CAD), confers the same relative risk of death from a cardiovascular cause as in patients with a previous cardiovascular event. The mean age of studied patients was 56.63±8.95 years. The commonest age group of study patients was 45-65 years in both groups (48.9% and 53.3 % in group I and group II respectively). Mean age difference was not statistically significant (p=0. 428).
Nearly similar pattern of age distribution was reported by Sarangi S, et al. 16 in their study in India. This observation was being consistent with the findings of different studies done in different countries [17] [18] [19] .
Out of sixty patients twenty three patients of tobacco user group I (n=30) and ten patients of tobacco non user group II (n=30) had peripheral artery disease which is statistically significant (p=0.003) between the two groups of patients. Univariate regression analysis of Gulf RACE 2009 revealed diabetes, family history of ischemic heart disease and tobacco use were independent variable for PAD(p=0.001). DM with tobacco user group showed strong association with PAD & adjusted odds ratio(OR) was 6.571 (CI 2.109-20.491). Out of 33(55%) patients who had PVD, coronary artery disease was found in 32 patients and it was statistically significant (p=.018). 80% male and 15% female had coronary artery disease, which was statistically insignificant. 51.3% male and 0.0332% female had peripheral artery disease which was statistically significant (p=0.018) and OR=6.526 (95%CI for OR 1.252-34.029) Sarangi S, et al. 16 and Al Thani, HA, et al. 20 was found statistically significant.
Various epidemiologic studies have shown that up to 50% of patients with PAD also have symptoms of cerebrovascular or heart disease 21 . In the PARTNERS study 22 of all the patients who were screened for vascular disease, only 13% had isolated PAD with no other manifestation of cardiovascular disease. Thirty two percent of the patients also had either coronary disease or cerebrovascular disease, and 24% had involvement in all 3 territories. The main cause of death in patients with PAD is ischemic heart disease (up to 50% of deaths in patients with PAD). Inversely, the prevalence of PAD in patients diagnosed with coronary disease reaches 30% 21 . The mortality in this group of patients is 2.5 times In overall ACS and STEMI, patients with PAD developed worse in-hospital outcomes in terms of greater rate of death, heart failure, recurrent ischemia, stroke, and major bleeding when compared to their non-PAD counterparts.
There was only one death in group who presented as STEMI and death due to ventricular septal rupture. Two patients of both groups was suffered acute left ventricular failure. Two patients of group I had diabetic foot ulcer due to peripheral artery disease. Significant difference was found in Al Thani HA, et al. 20 .
Conclusion
Prevalence of PAD in ACS Bangladeshi population is low in comparison to western population.Certain traditional risk factors are independent predictors for PAD necessitates aggressive preventive measures. Screening with ABI would allow the identification of a subgroup of CAD patients at particularly high risk and who could benefit from an aggressive medical treatment strategy. Detection of PAD in ACS patients might be a useful simple bedside tool for early detection of the risk stratification.
